Trademark: 97749337
Word
REGENERON ONCOLOGY
Status
Pending
Status Code
730
Status Date
Saturday, November 18, 2023
Serial Number
97749337
Mark Type
4000
Filing Date
Wednesday, January 11, 2023
Published for Opposition
Tuesday, April 11, 2023
Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Owner At Publication
Classifications
44 Providing information in the field of cancer research and treatment
"ONCOLOGY"
Trademark Events
Nov 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 18, 2023
Sou Extension 1 Granted
Nov 18, 2023
Sou Extension 1 Filed
Nov 18, 2023
Sou Teas Extension Received
Jun 6, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2023
Published For Opposition
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Mar 8, 2023
Approved For Pub - Principal Register
Mar 8, 2023
Examiner's Amendment Entered
Mar 8, 2023
Notification Of Examiners Amendment E-Mailed
Mar 8, 2023
Examiners Amendment E-Mailed
Mar 8, 2023
Examiners Amendment -Written
Mar 6, 2023
Assigned To Examiner
Feb 1, 2023
New Application Office Supplied Data Entered
Jan 14, 2023
New Application Entered
SUNSPECTOR
EOS
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov